Celldex Therapeutics shares owned by Boothbay Fund Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Boothbay Fund Management
from 13F filings
Historical chart of Boothbay Fund Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Boothbay Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.5M | 61k | 25.27 |
| 2024-09-30 | $6.1M | 180k | 33.99 |
| 2023-09-30 | $545k | 20k | 27.52 |
| 2023-03-31 | $1.5M | 42k | 35.98 |
| 2022-12-31 | $1.4M | 31k | 44.57 |
| 2022-09-30 | $1.0M | 37k | 28.10 |
| 2022-06-30 | $6.1M | 226k | 26.96 |
| 2022-03-31 | $5.7M | 166k | 34.07 |
| 2021-12-31 | $5.9M | 153k | 38.64 |
| 2021-09-30 | $8.5M | 158k | 53.98 |
| 2021-06-30 | $4.0M | 120k | 33.44 |
| 2021-03-31 | $1.5M | 74k | 20.59 |
| 2020-12-31 | $3.1M | 180k | 17.52 |
| 2020-09-30 | $2.8M | 186k | 14.83 |
| 2020-06-30 | $2.7M | 209k | 13.00 |